Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04520256
Other study ID # R01DK117857
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date September 22, 2020
Est. completion date May 18, 2023

Study information

Verified date March 2024
Source The Miriam Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

When delivered online, behavioral obesity treatments have the potential to reach large numbers of individuals with overweight/obesity and produce significant improvements in health and wellbeing. In order to maximize the public health benefit of disseminating these treatments online, this study will use the Multiphase Optimization Strategy (MOST) framework to most quickly and efficiently determine which, if any, of 5 innovative intervention components, alone or in combination, increases the proportion of patients achieving a ≥5% weight loss, and mean weight loss, after a 12-month online behavioral obesity treatment.


Description:

Decades of research have demonstrated that behavioral obesity treatments can produce clinically significant weight losses that improve health and disease risk/severity. However, these treatments have not been disseminated widely due to high costs and lack of qualified providers. The investigators therefore aim to develop and test a fully automated online obesity treatment that would produce clinically significant weight losses (i.e., ≥ 5 % of initial body weight) when delivered online. In order to maximize the public health impact of online obesity treatment, and advance the science of online behavioral intervention in general, it is imperative to evaluate innovative behavioral intervention components with the potential to optimize weight loss outcomes. Because digital health technology evolves rapidly, this research will use the Multiphase Optimization Strategy (MOST) framework to most quickly and efficiently determine which, if any, of 5 innovative intervention components, alone or in combination, increases the proportion of patients achieving a ≥5% weight loss, and mean weight loss, of the online Rx Weight loss (RxWL) program at 12- months. The 5 intervention components to be tested are: (a) Web-based virtual reality intervention for training in basic behavioral weight loss skills; tailored interactive intervention targeting (b) structured physical activity and (c) dysregulated eating; (d) a platform for social interaction including opportunities for friendly competition, and (e) interactive video feedback with content tailored to the unique needs of each participant and a focus on dietary skills. A sample of 384 individuals with BMI ≥ 25 will be randomized to receive RxWL and 0-5 of the experimental intervention components in a full factorial experiment. This design will allow the investigators to determine which intervention components maximize weight loss and whether there are favorable combinations of components. In addition, by evaluating the effects of each component on proximal outcomes (i.e., mediators) it will be possible learn not only which components are (or are not) effective but also why or how they exert their effects. This project advances the science of behavioral obesity treatment, and will directly impact the care of patients receiving RxWL.


Recruitment information / eligibility

Status Completed
Enrollment 384
Est. completion date May 18, 2023
Est. primary completion date May 18, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility - English language fluent and literate at the 6th grade level - Body mass index (BMI) between 25 and 50 kg/m-squared - Able to walk 2 city blocks without stopping - Not currently participating in another weight loss program - Not currently taking weight loss medication - Has not lost =5% of body weight in the 6 months prior to enrolling - Has not been pregnant within the 6 months prior to enrolling - Does not plan to become pregnant within 12 months of enrolling - Denies having a heart condition, chest pain during periods of activity or rest, or loss of consciousness in the 12 months prior to enrolling - Denies any medical condition that would affect the safety of participating in unsupervised physical activity - Denies any condition that would result in inability to follow the study protocol, including terminal illness, substance abuse, eating disorder (not including Binge Eating Disorder) and untreated major psychiatric illness

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Online Behavioral Weight Loss Program
A self-guided, online program that helps participants reduce energy intake and gradually increase physical activity.
Virtual Reality for Behavioral Weight Loss Skills Training
This program allows participants to practice behavioral weight loss skills using an online virtual reality system accessed via a Web browser.
Tailored Interactive Video Feedback
Video-recorded messages are used to provide periodic feedback on progress with weight loss, dietary change, and physical activity. Additional videos provide dietary skills training.
Tailored Intervention for Structured Physical Activity
Periodic self-assessment is used to guide selection of a physical activity goal. Home-based instructional videos are provided to help meet the selected goal.
Skills Training for Dysregulated Eating
Periodic self-assessment is used to guide selection of skills training modules designed to counter common causes of dysregulated eating (e.g., boredom, stress).
Platform for Social Support & Friendly Competition
An online platform is provided for participants to connect with each other, support each other, and compete on achievement of behavioral and weight loss milestones.

Locations

Country Name City State
United States Miriam Hospital Weight Control and Diabetes Resarch Center Providence Rhode Island

Sponsors (1)

Lead Sponsor Collaborator
The Miriam Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean weight change (percent of initial body weight) 12-month end of treatment
Primary Proportion of participants achieving at least 5% weight loss 12-month end of treatment
Secondary Weight loss self-efficacy Measured via the Weight Efficacy Life-Style Questionnaire (WEL). Scores range from 0 to 180; higher scores indicate a better outcome. 12-month end of treatment
Secondary Supportive accountability Measured via the Supportive Accountability Measure (SAM). Scores range from 17.14 to 100; higher scores indicate a better outcome. 12-month end of treatment
Secondary Social support for diet and exercise behaviors Measured via the Scales to Measure Social Support for Diet and Exercise Behaviors. Scores range from 10 to 75; higher scores indicate a better outcome. 12-month end of treatment
Secondary Internal disinhibition Measured via the Eating Inventory. Scores range from 0 to 16; lower scores indicate a better outcome. 12-month end of treatment
Secondary Structured physical activity Daily time spent in structured moderate to vigorous intensity physical activity will be measured using the ActiGraph GT9X Link 12-month end of treatment
Secondary Dietary quality Data collected via the National Cancer Institute Automated Self-Administered 24-hour recall system (ASA-24). Diet quality is measured by the The Health Eating Index, 2015, score that reflects conformance to the 2015 Dietary Guidelines for Americans. Higher scores indicate a better outcome. 12-month end of treatment
Secondary Dietary energy density Data collected via the National Cancer Institute Automated Self-Administered 24-hour recall system (ASA-24). Energy density of the diet is calculated as total energy intake from food ÷ total weight of the food. Lower scores indicate a better outcome. 12-month end of treatment
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03602001 - Attentive Eating for Weight Loss N/A
Recruiting NCT06269159 - The Power of 24-hour: Co-designing Intervention Components
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02996864 - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II N/A
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Terminated NCT03914066 - A Group-based Treatment of Overweight and Obesity in Primary Care N/A
Completed NCT03685656 - Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers N/A
Completed NCT05051579 - A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities Phase 2
Completed NCT04611477 - Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals N/A
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Completed NCT03599115 - Effects of Inhibitory Control Training in Eating Behaviors N/A
Recruiting NCT05938894 - Train Your Brain - Executive Function N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Recruiting NCT05987306 - A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Completed NCT04979234 - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome N/A
Not yet recruiting NCT06338709 - Clinical Study Protocol for the Assessment of Safety and Efficacy of the BARICLIP® N/A